The Microbiological Etiology of Fracture-Related Infection.


Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2022
Historique:
received: 02 05 2022
accepted: 14 06 2022
entrez: 25 7 2022
pubmed: 26 7 2022
medline: 27 7 2022
Statut: epublish

Résumé

Fracture-related infection (FRI) is an important complication related to orthopaedic trauma. Although the scientific interest with respect to the diagnosis and treatment of FRI is increasing, data on the microbiological epidemiology remains limited. Therefore, the primary aim of this study was to evaluate the microbiological epidemiology related to FRI, including the association with clinical symptoms and antimicrobial susceptibility data. The secondary aim was to analyze whether there was a relationship between the time to onset of infection and the microbiological etiology of FRI. FRI patients treated at the University Hospitals of Leuven, Belgium, between January 1st 2015 and November 24th 2019 were evaluated retrospectively. The microbiological etiology and antimicrobial susceptibility data were analyzed. Patients were classified as having an early (<2 weeks after implantation), delayed (2-10 weeks) or late-onset (> 10 weeks) FRI. One hundred ninety-one patients with 194 FRIs, most frequently involving the tibia (23.7%) and femur (18.6%), were included. This study revealed that in early FRIs, polymicrobial infections and infections including Enterobacterales and enterococcal species were more frequent. A time-based FRI classification is not meaningful to estimate the microbiological epidemiology and cannot be used to guide empiric antibiotic therapy. Large multicenter prospective studies are necessary to gain more insight into the added value of (broad) empirical antibiotic therapy.

Identifiants

pubmed: 35873162
doi: 10.3389/fcimb.2022.934485
pmc: PMC9300981
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

934485

Informations de copyright

Copyright © 2022 Depypere, Sliepen, Onsea, Debaveye, Govaert, IJpma, Zimmerli and Metsemakers.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Lancet. 2001 Jul 14;358(9276):135-8
pubmed: 11463434
J Orthop Surg (Hong Kong). 2008 Dec;16(3):339-42
pubmed: 19126902
J Bone Jt Infect. 2017 May 4;2(3):149-153
pubmed: 28540152
Clin Microbiol Infect. 2019 Mar;25(3):353-358
pubmed: 29803842
Antibiotics (Basel). 2020 Feb 05;9(2):
pubmed: 32033322
J Orthop Trauma. 2020 Jan;34(1):30-41
pubmed: 31567902
Am J Med. 2006 Nov;119(11):993.e7-10
pubmed: 17071171
Unfallchirurgie. 1986 Oct;12(5):241-6
pubmed: 3798588
J Chemother. 2003 Apr;15(2):134-8
pubmed: 12797389
Injury. 2018 Mar;49(3):505-510
pubmed: 28867644
Clin Microbiol Rev. 2018 Feb 14;31(2):
pubmed: 29444952
Arch Orthop Trauma Surg. 2020 Aug;140(8):1013-1027
pubmed: 31659475
Clin Microbiol Infect. 2016 Aug;22(8):732.e1-8
pubmed: 27181408
JAMA. 1998 May 20;279(19):1537-41
pubmed: 9605897
Int J Infect Dis. 2019 Apr;81:128-136
pubmed: 30772469
Clin Infect Dis. 2014 Jun;58(11):1554-63
pubmed: 24647022
Bone Joint J. 2021 Feb;103-B(2):213-221
pubmed: 33517743
BMC Infect Dis. 2020 Sep 10;20(1):667
pubmed: 32912204
J Bone Joint Surg Am. 1996 Apr;78(4):512-23
pubmed: 8609130
J Orthop Trauma. 2020 Jan;34(1):8-17
pubmed: 31855973
Clin Microbiol Infect. 2015 May;21 Suppl 1:S1-25
pubmed: 25596784
Antimicrob Agents Chemother. 1987 Feb;31(2):151-5
pubmed: 3566245
Antibiotics (Basel). 2022 Feb 22;11(3):
pubmed: 35326751
Clin Microbiol Infect. 2022 Apr;28(4):521-547
pubmed: 34923128
Injury. 2021 Jan;52(1):43-52
pubmed: 32620328
Antibiotics (Basel). 2021 Jul 29;10(8):
pubmed: 34438971
Eur J Trauma Emerg Surg. 2020 Dec;46(6):1341-1350
pubmed: 31312856
Clin Infect Dis. 2022 Jul 6;74(12):2089-2114
pubmed: 34864936
Clin Microbiol Infect. 2020 May;26(5):572-578
pubmed: 31446152
Clin Microbiol Infect. 2019 Jan;25(1):76-81
pubmed: 29649599
Clin Microbiol Infect. 2011 Jun;17(6):862-7
pubmed: 20825437
Clin Microbiol Infect. 2012 Dec;18(12):1176-84
pubmed: 23046277
Infez Med. 2008 Dec;16(4):204-8
pubmed: 19155685
J Shoulder Elbow Surg. 2021 Jan;30(1):16-26
pubmed: 32741563
Expert Rev Anti Infect Ther. 2020 Apr;18(4):307-321
pubmed: 32049563
Injury. 2018 Mar;49(3):511-522
pubmed: 27639601
J Orthop Surg Res. 2021 Aug 12;16(1):490
pubmed: 34384457
J Antimicrob Chemother. 2016 Feb;71(2):296-306
pubmed: 26542304
Science. 1999 May 21;284(5418):1318-22
pubmed: 10334980
J Arthroplasty. 2017 Aug;32(8):2496-2500
pubmed: 28390886
J Infect Dis. 2020 Jul 21;222(Suppl 2):S119-S131
pubmed: 32691833
Diagn Microbiol Infect Dis. 2019 Jul;94(3):255-259
pubmed: 30738691
Injury. 2022 Jun;53(6):1867-1879
pubmed: 35331479

Auteurs

Melissa Depypere (M)

Department of laboratory medicine, University Hospitals Leuven, Leuven, Belgium.
Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical Bacteriology and Mycology, KU Leuven, Leuven, Belgium.

Jonathan Sliepen (J)

Department of Trauma Surgery, University Medical Center Groningen, Groningen, Netherlands.

Jolien Onsea (J)

Department of Trauma Surgery, University Hospitals Leuven, Leuven, Belgium.
Department of Development and Regeneration, KU Leuven - University of Leuven, Leuven, Belgium.

Yves Debaveye (Y)

Department of Intensive Care Medicine, University Hospitals Leuven, Leuven, Belgium.

Geertje A M Govaert (GAM)

Department of Trauma Surgery, University of Utrecht, University Medical Center Utrecht, Utrecht, Netherlands.

Frank F A IJpma (FFA)

Department of Trauma Surgery, University Medical Center Groningen, Groningen, Netherlands.

Werner Zimmerli (W)

Basel University Medical Clinic, Kantonsspital Baselland, Liestal, Switzerland.

Willem-Jan Metsemakers (WJ)

Department of Trauma Surgery, University Hospitals Leuven, Leuven, Belgium.
Department of Development and Regeneration, KU Leuven - University of Leuven, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH